< Back to search
Filter
1
Active & Responsive

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

for
Cancer, Metastatic, Cancer, Cancer of Pancreas, Cancer of Liver,
Location: Scarborough ME, Worcester MA, Hartford CT, Norwalk CT,
Sponsor: Massive Bio, Inc.

Sex: All

Age: 0+

Code: NCT03452774

Recruiting
Active & Responsive

A Clinical Study of Sacituzumab Tirumotecan (MK-2870) in Patients With Bladder Cancer (MK-2870-027)

for
Non-Muscle Invasive Bladder Cancer
Location: Sherbrooke, Baltimore MD, Toronto, Tampa FL, Chicago IL,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT06637423

Phase1, Phase2, Recruiting
Active & Responsive

Improving Care for Rural Patients With Solid Tumors

for
Lung Cancer, Head and Neck Cancer, Thyroid Cancer,
Location: Greeley CO, Aurora CO, Loveland CO, Fort Collins CO,
Sponsor: University of Colorado, Denver

Sex: All

Age: 18 - 70+

Code: NCT04916990

Recruiting
Active & Responsive

A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors

for
NSCLC Adenocarcinoma, Gastroesophageal Cancer (GC),
Location: New York NY, East Brunswick NJ, Philadelphia PA,
Sponsor: IDEAYA Biosciences

Sex: All

Age: 18+

Code: NCT07277413

Phase1, Recruiting
Active & Responsive

Collecting and Studying Blood and Tissue Samples From Patients With Locally Recurrent or Metastatic Prostate or Bladder/Urothelial Cancer

for
Localized Renal Pelvis and Ureter Urothelial Carcinoma,
Location: Seattle WA
Sponsor: University of Washington

Sex: Male

Age: 18+

Code: NCT01050504

Recruiting

Interested in new bladder cancer trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image
Active & Responsive

Bladder EpiCheck Product Development Study

for
Suspicion of Bladder Cancer, NMIBC Surveillance
Location: Towson MD, San Diego CA
Sponsor: Nucleix Ltd.

Sex: All

Age: 22+

Code: NCT07514143

Recruiting
Active & Responsive

KEYMAKER-U04 Substudy 04D: A Clinical Study of New Treatments Given With Enfortumab Vedotin and Pembrolizumab in People With Urothelial Cancer (MK-3475-04D/KEYMAKER-U04)

for
Bladder Cancer
Location: Cleveland OH, Chicago IL, Salt Lake City UT,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT07232602

Phase1, Phase2, Recruiting
Active & Responsive

Gemcitabine/Cisplatin Plus Cemiplimab With or Without Fianlimab in Localized Muscle-invasive Bladder Cancer (NeoSTOP-IT)

for
Bladder Cancer, Muscle-Invasive Bladder Carcinoma
Location: New York NY
Sponsor: Columbia University

Sex: All

Age: 18+

Code: NCT06571708

Phase2, Recruiting
Active & Responsive

Study of CP-383 in Patients With Advanced or Metastatic Solid Tumors

for
Solid Tumor Malignancies, Colorectal Carcinoma,
Location: Philadelphia PA, Fairfax VA, Orlando FL,
Sponsor: Tasca Therapeutics

Sex: All

Age: 18+

Code: NCT07030257

Phase1, Phase2, Recruiting
Active & Responsive

Futibatinib in Combination With Durvalumab Prior to Cystectomy for the Treatment of Muscle-Invasive Bladder Cancer Patients Who Are Ineligible for Cisplatin-based Therapy

for
Bladder Urothelial Carcinoma, Muscle Invasive Bladder Carcinoma,
Location: Cleveland OH, Columbus OH
Sponsor: Yuanquan Yang

Sex: All

Age: 18+

Code: NCT06263153

Phase2, Recruiting
Active & Responsive

Mood Alterations in the Patients With Non-Muscle Invasive Bladder Cancer Treated With BCG

for
Non-Muscle Invasive Bladder Cancer
Location: Washington D.C. DC
Sponsor: Johns Hopkins University

Sex: All

Age: 18+

Code: NCT05672615

Recruiting
Active & Responsive

Increasing Pre-Surgical Identification of Muscle Invasive Tumor Evaluations Prior to Planned Cystectomy (INSITE)

for
Urothelial Carcinoma,
Location: Philadelphia PA, Omaha NE
Sponsor: Fox Chase Cancer Center

Sex: All

Age: 18+

Code: NCT06396533

Recruiting
Active & Responsive

Cabozantinib in Combination With Enfortumab Vedotin for Locally Advanced or Metastatic Urothelial Cancer

for
Infiltrating Bladder Urothelial Carcinoma With Squamous Differentiation,
Location: Atlanta GA
Sponsor: Emory University

Sex: All

Age: 18+

Code: NCT04878029

Phase1, Recruiting
Active & Responsive

A Randomized Trial of Bicalutamide in Non-Muscle Invasive Bladder Cancer

for
Non-Muscle Invasive Bladder Urothelial Carcinoma,
Location: Madison WI, Tucson AZ
Sponsor: University of Wisconsin, Madison

Sex: Male

Age: 18+

Code: NCT05521698

Phase1, Recruiting
Active & Responsive

Assessing Symptom and Mood Dynamics in Pain Using the Smartphone Application SOMA

for
Chronic Pain, Acute Pain, Post Operative Pain,
Location: Providence RI
Sponsor: Brown University

Sex: All

Age: 18+

Code: NCT05754190

Recruiting
Active & ResponsiveNew

Alternating Chemo-immunotherapy and FGFR Inhibitor for FGFR-positive Biliary or Cholangiocarcinoma

for
Locally Advanced Ampulla of Vater Carcinoma,
Location: Columbus OH
Sponsor: Ohio State University Comprehensive Cancer Center

Sex: All

Age: 18+

Code: NCT07780838

Phase2, Recruiting
Active & Responsive

Quebec Pancreas Cancer Study

for
Pancreas Cancer, Pancreatic Cancer, Pancreas Neoplasm,
Location: Montreal
Sponsor: George Zogopoulos

Sex: All

Age: 18+

Code: NCT04104230

Recruiting
Active & Responsive

Home Neuromodulation for Neurogenic Bladder Management in Spinal Cord Injury

for
Spinal Cord Injury (SCI), Neurogenic Bladder (NB)
Location: Houston TX
Sponsor: The University of Texas Health Science Center, Houston

Sex: All

Age: 18 - 70+

Code: NCT07264868

Recruiting
New

Acupuncture and Exercise for EV-Pembro-Induced Peripheral Neuropathy

for
Metastatic Bladder Cancer, Peripheral Neuropathy,
Location: Boston MA
Sponsor: Dana-Farber Cancer Institute

Sex: All

Age: 18+

Code: NCT07548476

Recruiting

LaserEn: SOLTIVE™ Thulium Laser Fiber En Bloc Resection of Bladder Tumors

for
Bladder Cancer, Surgery
Location: Kansas City KS
Sponsor: University of Kansas Medical Center

Sex: All

Age: 18+

Code: NCT04979156

Recruiting